Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 64 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
GENETIX from Antwerpen, company number BE0666850650, closed financial year 2025 with a result of € 41,247 after tax. For that financial year GENETIX recorded a gross margin of € 304,839 and equity of € 86,792. Compared with financial year 2024, the result moved from € 44,596 to € 41,247. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 8, 2026.
€ 86,792
▲ 23% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 41,247
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 105,530
▲ 85% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 25,000 paid out
61 % of the profit went to the shareholders, mostly to GENESIS ENTERPRISE (50 % of the shares). That is where the money ends up.
People and assets in 2025
€ 228,187
▼ 10% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 86,683
▼ 20% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 48,931
▼ 19% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 224,888 | € 335,238 | € 342,825 | € 304,839 | ▼ 11% |
| Profit after taxes | € 4,824 | € 47,246 | € 44,596 | € 41,247 | ▼ 8% |
| Equity | € 73,703 | € 95,949 | € 70,545 | € 86,792 | ▲ 23% |
| Total debts | € 167,762 | € 171,564 | € 272,571 | € 204,321 | ▼ 25% |
| Cash | € 94,607 | € 54,796 | € 56,947 | € 105,530 | ▲ 85% |
| Retained profit | € 55,103 | € 77,349 | € 51,945 | € 68,192 | ▲ 31% |
| Dividend | € 0 | € 25,000 | € 70,000 | € 25,000 | ▼ 64% |
| Balance sheet total | € 241,465 | € 267,513 | € 343,116 | € 291,113 | ▼ 15% |
Key figures of GENETIX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GENETIX?
What happened at GENETIX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 41,247 (▼ 8% vs 2024). filed late Source: NBB ↗
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
- Genesis Enterprise BVBA became a director. NBB
- Farhad Eshaghzey became a director. NBB
In short
From € 4,824 profit in 2022 to € 41,247 profit in 2025.
Paid € 66,796 in corporate taxes since 2022.
Best year ever: 2023, with € 47,246 profit.
Paid out € 120,000 in dividends to the owners in total.
A new publication or filing at GENETIX? We notify you, reason included.
Follow GENETIXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of GENESIS ENTERPRISE, OPUS HOLDING comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
GENETIXBehind GENETIX are Genesis Enterprise BVBA and Farhad Eshaghzey. The shares are held by GENESIS ENTERPRISE (50%) and OPUS HOLDING (50%).
Directors
According to the 2025 annual accounts
since 2016
since 2016
Shareholders
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Berchemstadionstraat 77
2600 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0666.850.650
- VAT number
- BE 0666.850.650
- Registered office
- Berchemstadionstraat 77, 2600 Antwerpen
- Names & denominations
- GENETIX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 December 2016
- Peppol
- Active · Active since 2 Feb 2025
- Activities · NACE
Niet-gespecialiseerde detailhandel waarbij voedings- en genotmiddelen overheersen
Detailhandel in motorbrandstoffen
Detailhandel in niet-gespecialiseerde winkels waarbij voedings- en genotmiddelen overheersen (verkoopsoppervlakte < 100 m²)
Activiteiten van eetgelegenheden met beperkte bediening, muv mobiele eetgelegenheden
Detailhandel in kranten en andere tijdschriften
Detailhandel in dranken, algemeen assortiment
Eetgelegenheden met beperkte bediening
Detailhandel in kranten en kantoorbehoeften in gespecialiseerde winkels